Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre,... by Ceresoli, Giovanni L, MD, Aerts, Joachim G, Prof, Dziadziuszko, Rafal, Prof, Ramlau, Rodryg, MD, Cedres, Susana, MD, van Meerbeeck, Jan P, Prof, Mencoboni, Manlio, MD, Planchard, David, MD, Chella, Antonio, MD, Crinò, Lucio, MD, Krzakowski, Maciej, MD, Rüssel, Jörn, MD, Maconi, Antonio, MD, Gianoncelli, Letizia, MD, Grosso, Federica, MD

Get full text

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study by Barlesi, Fabrice, Prof, Vansteenkiste, Johan, Prof, Spigel, David, MD, Ishii, Hidenobu, MD, Garassino, Marina, MD, de Marinis, Filippo, MD, Özgüroğlu, Mustafa, Prof, Szczesna, Aleksandra, MD, Polychronis, Andreas, PhD, Uslu, Ruchan, MD, Krzakowski, Maciej, Prof, Lee, Jong-Seok, Prof, Calabrò, Luana, MD, Arén Frontera, Osvaldo, MD, Ellers-Lenz, Barbara, MS, Bajars, Marcis, MD, Ruisi, Mary, MD, Park, Keunchil, Prof

Get full text

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled... by Reck, Martin, Dr, Kaiser, Rolf, MD, Mellemgaard, Anders, MD, Douillard, Jean-Yves, Prof, Orlov, Sergey, Prof, Krzakowski, Maciej, Prof, von Pawel, Joachim, MD, Gottfried, Maya, MD, Bondarenko, Igor, Prof, Liao, Meilin, Prof, Gann, Claudia-Nanette, MD, Barrueco, José, PhD, Gaschler-Markefski, Birgit, PhD, Novello, Silvia, Prof

Get full text

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial by Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof

Get full text

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study by Ciuleanu, Tudor, MD, Brodowicz, Thomas, MD, Zielinski, Christoph, Prof, Kim, Joo Hang, MD, Krzakowski, Maciej, Prof, Laack, Eckart, MD, Wu, Yi-Long, Prof, Bover, Isabel, MD, Begbie, Stephen, MD, Tzekova, Valentina, MD, Cucevic, Branka, MD, Pereira, Jose Rodrigues, MD, Yang, Sung Hyun, MD, Madhavan, Jayaprakash, MD, Sugarman, Katherine P, MD, Peterson, Patrick, PhD, John, William J, MD, Krejcy, Kurt, MD, Belani, Chandra P, Dr

Get full text

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX s... by Pirker, Robert, Prof, Pereira, Jose R, MD, von Pawel, Joachim, MD, Krzakowski, Maciej, Prof, Ramlau, Rodryg, MD, Park, Keunchil, Prof, de Marinis, Filippo, MD, Eberhardt, Wilfried EE, MD, Paz-Ares, Luis, MD, Störkel, Stephan, Prof, Schumacher, Karl-Maria, MD, von Heydebreck, Anja, PhD, Celik, Ilhan, Prof, O'Byrne, Kenneth J, Prof

Get full text

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial by Pirker, Robert, Prof, Pereira, Jose R, MD, Szczesna, Aleksandra, MD, von Pawel, Joachim, MD, Krzakowski, Maciej, Prof, Ramlau, Rodryg, MD, Vynnychenko, Ihor, MD, Park, Keunchil, Prof, Yu, Chih-Teng, MD, Ganul, Valentyn, Prof, Roh, Jae-Kyung, Prof, Bajetta, Emilio, Prof, O'Byrne, Kenneth, Prof, de Marinis, Filippo, MD, Eberhardt, Wilfried, MD, Goddemeier, Thomas, Dipl Stat, Emig, Michael, MD, Gatzemeier, Ulrich, MD

Get full text

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-bli... by Belani, Chandra P, Prof, Brodowicz, Thomas, MD, Ciuleanu, Tudor E, MD, Krzakowski, Maciej, Prof, Yang, Sung Hyun, MD, Franke, Fábio, MD, Cucevic, Branka, MD, Madhavan, Jayaprakash, MD, Santoro, Armando, MD, Ramlau, Rodryg, MD, Liepa, Astra M, PharmD, Visseren-Grul, Carla, MD, Peterson, Patrick, PhD, John, William J, MD, Zielinski, Christoph C, Prof

Get full text